2f:I[703058,["/_next/static/immutable/chunks/3bhq_5eh1d760.js","/_next/static/immutable/chunks/1855-ogyi8eh4.js","/_next/static/immutable/chunks/2pfsjpn6k6zlg.js","/_next/static/immutable/chunks/26c7v3_3uwnwu.js","/_next/static/immutable/chunks/25a3ozcrvi1ff.js","/_next/static/immutable/chunks/2r4wx50nvjh_4.js","/_next/static/immutable/chunks/23fsw06hsi5b1.js","/_next/static/immutable/chunks/06_yt270h41rg.js","/_next/static/immutable/chunks/3ezsiz-7shkna.js","/_next/static/immutable/chunks/20x2y96ldu5wx.js","/_next/static/immutable/chunks/2lxntcm3pd1_h.js","/_next/static/immutable/chunks/00dgco8irq3jw.js","/_next/static/immutable/chunks/00nwe-kq0rboc.js","/_next/static/immutable/chunks/2051ffx3xzio9.js"],"PaperListPageClient"] 30:T648,Amid a large-scale resurgence of pertussis in Japan in 2025, concern is growing about the spread of macrolide-resistant Bordetella pertussis (MRBP)-prevalent in China-posing a clinical challenge, particularly in infants. We describe a term 6-week-old unvaccinated infant with life-threatening MRBP. Diagnosis was confirmed by culture and multiplex PCR. The isolate harbored the 23S rRNA A2047G mutation. Daily microbiology (Gram stain, culture, quantitative PCR) was performed on nasopharyngeal swabs and lower-airway aspirates. The infant received empiric azithromycin and a 14-day course of sulfamethoxazole-trimethoprim (SMX-TMP) and recovered without sequelae. Nasopharyngeal cultures became negative by Day 2 of SMX-TMP therapy, and lower-airway aspirate cultures by Day 3. Nasopharyngeal quantitative PCR was below the detection limit by Day 7. Lower-airway quantitative PCR declined through Day 7, and sampling ceased after extubation. These observations suggest that bacteriologic clearance with SMX-TMP may occur on a time frame similar to that used to discontinue precautions for macrolide-susceptible disease, commonly five days after starting effective therapy. During the current resurgence in Japan, transmission appears concentrated among school-aged children, whereas the national vaccination program targets only those under two years of age. Introducing booster doses at 5-6 and 11-12 years may help reduce school-based transmission. In addition, maternal booster vaccination during pregnancy could protect young infants through the transplacental transfer of maternal pertussis antibodies.31:T883,Influenza and tetanus-diphtheria-acellular pertussis (Tdap) vaccinations during pregnancy offer protection to infants from infections. However, evidence about their effectiveness against hospitalization and emergency department (ED) visits associated with influenza and pertussis remains limited. This study aimed to evaluate the association of maternal influenza and Tdap vaccinations with influenza- and pertussis-related hospitalizations and ED visits in infants younger than 6 months. This population-based cohort study used the health care utilization databases from the Lombardy region of Italy. Pregnant individuals who received the influenza and Tdap vaccine among all live-birth pregnancies in 2018 to 2022 were included. Each vaccinated mother was matched with a nonvaccinated counterpart based on month and year of delivery, gestational age at birth, and pregnancy multiplicity. Analyses were performed from April 2024 to February 2025. Exposures of interest were influenza and Tdap vaccinations during pregnancy. The primary outcomes were infant hospitalizations or ED visits due to influenza and pertussis. Cox regression models were fitted to estimate the hazard ratio (HR) of each outcome associated with the corresponding maternal vaccine. Vaccine effectiveness (VE) was calculated as VE = (1 - HR) × 100%. This study included 53 448 pregnant individuals who received the Tdap vaccine and 5347 who received influenza vaccine. The maternal vaccination coverage (ie, proportion of vaccinated pregnant individuals among those eligible) was 5359 (6.4%) for influenza and 70 119 (41.0%) for Tdap, respectively. Infants born to mothers who received the influenza and Tdap vaccine had a lower risk of hospitalization or ED visit for influenza (VE, 69.7%; 95% CI, 8.7%-90.0%) and pertussis (VE, 88.6%; 95% CI, 11.5%-98.5%), respectively. This study found that maternal influenza and Tdap vaccinations were associated with reduced influenza- and pertussis-related hospitalization or ED visits in infants younger than 6 months. Given the low vaccination coverage, it is crucial to implement maternal vaccination campaigns to enhance infant health outcomes.32:Td59, Importance Influenza and tetanus-diphtheria-acellular pertussis (Tdap) vaccinations during pregnancy offer protection to infants from infections. However, evidence about their effectiveness against hospitalization and emergency department (ED) visits associated with influenza and pertussis remains limited. Objective This study aimed to evaluate the association of maternal influenza and Tdap vaccinations with influenza- and pertussis-related hospitalizations and ED visits in infants younger than 6 months. Design, Setting, and Participants This population-based cohort study used the health care utilization databases from the Lombardy region of Italy. Pregnant individuals who received the influenza and Tdap vaccine among all live-birth pregnancies in 2018 to 2022 were included. Each vaccinated mother was matched with a nonvaccinated counterpart based on month and year of delivery, gestational age at birth, and pregnancy multiplicity. Analyses were performed from April 2024 to February 2025. Exposures Exposures of interest were influenza and Tdap vaccinations during pregnancy. Main Outcomes and Measures The primary outcomes were infant hospitalizations or ED visits due to influenza and pertussis. Cox regression models were fitted to estimate the hazard ratio (HR) of each outcome associated with the corresponding maternal vaccine. Vaccine effectiveness (VE) was calculated as VE = (1 − HR) × 100%. Results This study included 53 448 pregnant individuals who received the Tdap vaccine and 5347 who received influenza vaccine. The maternal vaccination coverage (ie, proportion of vaccinated pregnant individuals among those eligible) was 5359 (6.4%) for influenza and 70 119 (41.0%) for Tdap, respectively. Infants born to mothers who received the influenza and Tdap vaccine had a lower risk of hospitalization or ED visit for influenza (VE, 69.7%; 95% CI, 8.7%-90.0%) and pertussis (VE, 88.6%; 95% CI, 11.5%-98.5%), respectively. Conclusions and Relevance This study found that maternal influenza and Tdap vaccinations were associated with reduced influenza- and pertussis-related hospitalization or ED visits in infants younger than 6 months. Given the low vaccination coverage, it is crucial to implement maternal vaccination campaigns to enhance infant health outcomes. 33:T8b8,Childhood vaccination rates have declined in many US states, contributing to outbreaks of vaccine-preventable diseases and raising concerns about policy effectiveness amid growing vaccine hesitancy. To evaluate the association between state repeal of nonmedical vaccine exemptions and kindergarten vaccination rates. This cross-sectional study used annual state-level kindergarten vaccination and exemption data from the Centers for Disease Control and Prevention for school years 2011 through 2023. A staggered difference-in-differences design compared states that repealed nonmedical exemptions with states that maintained such policies. The study included kindergarten students in US public and private schools across 37 to 43 states, depending on the outcome measure. Total repeal of nonmedical vaccine exemptions in California (2015), New York (2019), Maine (2019), and Connecticut (2021). Partial repeal in Vermont (2015) and Washington (2019) was analyzed separately. State-level kindergarten vaccination rates for diphtheria-tetanus-acellular pertussis (DTaP), hepatitis B, measles-mumps-rubella (MMR), and poliovirus (polio) vaccines; rates of medical and nonmedical exemptions. Among 4 states with total repeal affecting approximately 2.8 million kindergarten students, repeal of nonmedical exemptions reduced overall exemption rates by 3.2 (95% CI, 1.9-4.4) percentage points within 3 years. Compared with nonrepeal states, vaccination rates rose by 4.1 (95% CI, 3.3-4.9) percentage points for DTaP, 2.8 (95% CI, 2.1-3.5) percentage points for hepatitis B, 4.0 (95% CI, 3.1-4.9) percentage points for MMR, and 3.8 (95% CI, 2.9-4.6) percentage points for polio. Minimal substitution toward medical exemptions occurred, an increase of only 0.4 (95% CI, 0.04-0.7) percentage points. Partial repeal of nonmedical exemptions demonstrated smaller, less persistent increases in vaccination rates. State repeal of nonmedical vaccine exemptions was associated with increased kindergarten vaccination rates with minimal substitution toward medical exemptions. These findings suggest that nonmedical exemption repeal played a role in maintaining vaccination coverage in repeal states during a period of heightened vaccine hesitancy.34:Td8c, Importance Childhood vaccination rates have declined in many US states, contributing to outbreaks of vaccine-preventable diseases and raising concerns about policy effectiveness amid growing vaccine hesitancy. Objective To evaluate the association between state repeal of nonmedical vaccine exemptions and kindergarten vaccination rates. Design, Setting, and Participants This cross-sectional study used annual state-level kindergarten vaccination and exemption data from the Centers for Disease Control and Prevention for school years 2011 through 2023. A staggered difference-in-differences design compared states that repealed nonmedical exemptions with states that maintained such policies. The study included kindergarten students in US public and private schools across 37 to 43 states, depending on the outcome measure. Exposures Total repeal of nonmedical vaccine exemptions in California (2015), New York (2019), Maine (2019), and Connecticut (2021). Partial repeal in Vermont (2015) and Washington (2019) was analyzed separately. Main Outcomes and Measures State-level kindergarten vaccination rates for diphtheria-tetanus-acellular pertussis (DTaP), hepatitis B, measles-mumps-rubella (MMR), and poliovirus (polio) vaccines; rates of medical and nonmedical exemptions. Results Among 4 states with total repeal affecting approximately 2.8 million kindergarten students, repeal of nonmedical exemptions reduced overall exemption rates by 3.2 (95% CI, 1.9-4.4) percentage points within 3 years. Compared with nonrepeal states, vaccination rates rose by 4.1 (95% CI, 3.3-4.9) percentage points for DTaP, 2.8 (95% CI, 2.1-3.5) percentage points for hepatitis B, 4.0 (95% CI, 3.1-4.9) percentage points for MMR, and 3.8 (95% CI, 2.9-4.6) percentage points for polio. Minimal substitution toward medical exemptions occurred, an increase of only 0.4 (95% CI, 0.04-0.7) percentage points. Partial repeal of nonmedical exemptions demonstrated smaller, less persistent increases in vaccination rates. Conclusions and Relevance State repeal of nonmedical vaccine exemptions was associated with increased kindergarten vaccination rates with minimal substitution toward medical exemptions. These findings suggest that nonmedical exemption repeal played a role in maintaining vaccination coverage in repeal states during a period of heightened vaccine hesitancy. 25:[[["$","script","0",{"type":"application/ld+json","dangerouslySetInnerHTML":{"__html":"{\"@context\":\"https://schema.org\",\"@type\":\"CollectionPage\",\"name\":\"Pertussis: condition Research & Clinical Takeaways\",\"description\":\"Explore peer-reviewed papers on Pertussis (condition). Clinician-written summaries and actionable practice insights. Updated daily.\",\"url\":\"https://www.reachrx.ai/hub/tag/condition/Pertussis\",\"breadcrumb\":{\"@type\":\"BreadcrumbList\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https://www.reachrx.ai\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Research Hub\",\"item\":\"https://www.reachrx.ai/hub\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Conditions\",\"item\":\"https://www.reachrx.ai/hub/tag/condition\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"Pertussis\",\"item\":\"https://www.reachrx.ai/hub/tag/condition/Pertussis\"}]}}"}}]],["$","$L2f",null,{"title":"Pertussis: Research & Clinical Takeaways","description":"Discover peer-reviewed research on Pertussis with concise clinician summaries and next-step guidance.","papers":[{"doi":"10.1016/s2213-2600(26)00260-2","pmid":"42594935","title":"A Pox on Fools: The Grifters and Cynics Who Want Us To Reject Vaccines","journal_title":"The Lancet Respiratory Medicine","journal_issn":"2213-2600","published_at":"2026-08-13T00:00:00.000Z","url":"https://doi.org/10.1016/s2213-2600(26)00260-2","source_score":3,"is_retracted":false,"is_open_access":false,"raw_metadata":{"pubmed":true,"crossref":true,"unpaywall":true},"created_at":"2026-08-21T06:28:11.269Z","updated_at":"2026-08-21T06:28:11.269Z","tags":[{"paper_doi":"10.1016/s2213-2600(26)00260-2","tag_type":"age_group","value":"mixed","value_numeric":null},{"paper_doi":"10.1016/s2213-2600(26)00260-2","tag_type":"category","value":"Respiratory System","value_numeric":null},{"paper_doi":"10.1016/s2213-2600(26)00260-2","tag_type":"condition","value":"Measles","value_numeric":null},{"paper_doi":"10.1016/s2213-2600(26)00260-2","tag_type":"condition","value":"Pertussis","value_numeric":null},{"paper_doi":"10.1016/s2213-2600(26)00260-2","tag_type":"condition","value":"Poliomyelitis","value_numeric":null},{"paper_doi":"10.1016/s2213-2600(26)00260-2","tag_type":"condition","value":"Vaccine-Preventable Diseases","value_numeric":null},{"paper_doi":"10.1016/s2213-2600(26)00260-2","tag_type":"impact_flag","value":"safety_signal","value_numeric":null},{"paper_doi":"10.1016/s2213-2600(26)00260-2","tag_type":"level_of_evidence","value":"7","value_numeric":null},{"paper_doi":"10.1016/s2213-2600(26)00260-2","tag_type":"modality","value":"Vaccine","value_numeric":null},{"paper_doi":"10.1016/s2213-2600(26)00260-2","tag_type":"study_design","value":"Book Review","value_numeric":null},{"paper_doi":"10.1016/s2213-2600(26)00260-2","tag_type":"warning","value":"Study design is classified as 'Book Review'; level of evidence is set to 7 (expert opinion/narrative) accordingly.","value_numeric":null},{"paper_doi":"10.1016/s2213-2600(26)00260-2","tag_type":"warning","value":"The 'safety_signal' impact flag reflects the documented public health consequences of declining vaccination coverage described in the review, not a pharmacovigilance signal from a clinical trial.","value_numeric":null},{"paper_doi":"10.1016/s2213-2600(26)00260-2","tag_type":"warning","value":"This is a book review, not a clinical study — no patient data, statistics, or experimental methodology are present. Tags and summaries reflect the policy/public health content of the review rather than empirical findings.","value_numeric":null}],"summaries":{"what_studied":"This is a book review of *A Pox on Fools: The Grifters and Cynics Who Want Us To Reject Vaccines* by Thomas Levenson, which examines the history of vaccine scepticism and the political dismantling of US vaccine infrastructure, with RFK Jr's leadership of HHS as its central focus.","key_result":"The book documents specific policy actions since 2025, including appointment of vaccine critics to CDC advisory committees and withdrawal of ~$500 million in mRNA vaccine funding; it argues vaccine scepticism is an existential threat to public health, set against the backdrop of the largest US measles outbreak since 1991.","limitations":"This is a book review, not a primary research study — no empirical data, methods, or outcomes are reported. The reviewed book itself is described as not including original interviews.","practice_takeaway":"Clinicians should be aware of the accelerating erosion of US vaccine infrastructure and be prepared to counter vaccine misinformation with historical context — reminding patients of the concrete harms of vaccine-preventable diseases before outbreaks force the lesson."}},{"doi":"10.1016/j.jiac.2026.102907","pmid":"41520787","title":"Microbiologic clearance in macrolide-resistant Bordetella pertussis: An infant treated with sulfamethoxazole-trimethoprim — A case timeline","journal_title":"Journal of Infection and Chemotherapy","journal_issn":"1341-321X","published_at":"2026-01-12T00:00:00.000Z","url":"https://doi.org/10.1016/j.jiac.2026.102907","source_score":14,"is_retracted":false,"is_open_access":false,"raw_metadata":{"ooir":{"day":"2026-01-14","doi":"10.1016/j.jiac.2026.102907","days":"7","issn":"1341-321X","rank":"7","field":"Clinical Medicine","score":"14","category":"Infectious Diseases","categories":["Infectious Diseases"],"_categories":["Infectious Diseases"]},"pubmed":{"doi":"10.1016/j.jiac.2026.102907","title":"Microbiologic clearance in macrolide-resistant Bordetella pertussis: An infant treated with sulfamethoxazole-trimethoprim - A case timeline.","journal":"Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy","methods":"","results":"","abstract":"$30","keywords":["Bordetella pertussis","Infant","Macrolide-resistant","Quantitative Polymerase Chain Reaction","Trimethoprim-sulfamethoxazole combination"],"pubmed_id":"41520787","conclusions":"","publication_date":"2026-01-12T00:00:00"},"crossref":{"DOI":"10.1016/j.jiac.2026.102907","URL":"https://doi.org/10.1016/j.jiac.2026.102907","ISSN":["1341-321X"],"link":[{"URL":"https://api.elsevier.com/content/article/PII:S1341321X2600005X?httpAccept=text/xml","content-type":"text/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https://api.elsevier.com/content/article/PII:S1341321X2600005X?httpAccept=text/plain","content-type":"text/plain","content-version":"vor","intended-application":"text-mining"}],"page":"102907","type":"journal-article","issue":"2","score":1,"title":["Microbiologic clearance in macrolide-resistant Bordetella pertussis: An infant treated with sulfamethoxazole-trimethoprim — A case timeline"],"author":[{"given":"Yu","family":"Kuramochi","sequence":"first","affiliation":[]},{"given":"Meiwa","family":"Shibata","sequence":"additional","affiliation":[]},{"given":"Mikako","family":"Morinaga","sequence":"additional","affiliation":[]},{"given":"Tomoyuki","family":"Tame","sequence":"additional","affiliation":[]},{"given":"Kazue","family":"Kinoshita","sequence":"additional","affiliation":[]},{"given":"Osamu","family":"Saito","sequence":"additional","affiliation":[]},{"given":"Yuho","family":"Horikoshi","sequence":"additional","affiliation":[]}],"issued":{"date-parts":[[2026,2]]},"member":"78","prefix":"10.1016","source":"Crossref","volume":"32","created":{"date-time":"2026-01-09T16:10:37Z","timestamp":1767975037000,"date-parts":[[2026,1,9]]},"indexed":{"date-time":"2026-01-12T11:52:46Z","timestamp":1768218766269,"date-parts":[[2026,1,12]]},"license":[{"URL":"https://www.elsevier.com/tdm/userlicense/1.0/","start":{"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000,"date-parts":[[2026,2,1]]},"delay-in-days":0,"content-version":"tdm"},{"URL":"https://www.elsevier.com/legal/tdmrep-license","start":{"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000,"date-parts":[[2026,2,1]]},"delay-in-days":0,"content-version":"tdm"}],"subject":[],"abstract":null,"language":"en","relation":{},"resource":{"primary":{"URL":"https://linkinghub.elsevier.com/retrieve/pii/S1341321X2600005X"}},"subtitle":[],"assertion":[{"name":"publisher","label":"This article is maintained by","value":"Elsevier"},{"name":"articletitle","label":"Article Title","value":"Microbiologic clearance in macrolide-resistant Bordetella pertussis: An infant treated with sulfamethoxazole-trimethoprim — A case timeline"},{"name":"journaltitle","label":"Journal Title","value":"Journal of Infection and Chemotherapy"},{"name":"articlelink","label":"CrossRef DOI link to publisher maintained version","value":"https://doi.org/10.1016/j.jiac.2026.102907"},{"name":"content_type","label":"Content Type","value":"article"},{"name":"copyright","label":"Copyright","value":"© 2026 Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Infection Prevention and Control. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies."}],"deposited":{"date-time":"2026-01-12T08:50:08Z","timestamp":1768207808000,"date-parts":[[2026,1,12]]},"issn-type":[{"type":"print","value":"1341-321X"}],"published":{"date-parts":[[2026,2]]},"publisher":"Elsevier BV","reference":[{"DOI":"10.1097/00006454-199505000-00010","key":"10.1016/j.jiac.2026.102907_bib1","year":"1995","issue":"5","author":"Lewis","volume":"14","first-page":"388","unstructured":null,"article-title":"Pertussis caused by an erythromycin-resistant strain of Bordetella pertussis","journal-title":"Pediatr Infect Dis J","doi-asserted-by":"crossref"},{"DOI":"10.3390/antibiotics11111570","key":"10.1016/j.jiac.2026.102907_bib2","year":"2022","issue":"11","author":"Ivaska","volume":"11","first-page":"1570","unstructured":null,"article-title":"Macrolide resistance in Bordetella pertussis: current situation and future challenges","journal-title":"Antibiotics (Basel)","doi-asserted-by":"crossref"},{"DOI":null,"key":"10.1016/j.jiac.2026.102907_bib3","year":"2021","issue":null,"author":"Feng","volume":"8","first-page":"100098","unstructured":null,"article-title":"Wirsing von König C.H. Emerging macrolide resistance in Bordetella pertussis in mainland China: findings and warning from the Global Pertussis Initiative","journal-title":"Lancet Reg Health West Pac","doi-asserted-by":null},{"DOI":"10.1016/j.jinf.2024.106289","key":"10.1016/j.jiac.2026.102907_bib4","year":"2024","issue":null,"author":"Liu","volume":"89","first-page":null,"unstructured":null,"article-title":"Global resurgence of pertussis: a perspective from China","journal-title":"J Infect","doi-asserted-by":"crossref"},{"DOI":"10.1016/j.jgar.2022.10.007","key":"10.1016/j.jiac.2026.102907_bib8","year":"2022","issue":null,"author":"Koide","volume":"31","first-page":"263","unstructured":null,"article-title":"Genotyping and macrolide-resistant mutation of Bordetella pertussis in East and South-East Asia","journal-title":"J Glob Antimicrob Resist","doi-asserted-by":"crossref"},{"DOI":"10.7883/yoken.JJID.2019.421","key":"10.1016/j.jiac.2026.102907_bib9","year":"2020","issue":"5","author":"Yamaguchi","volume":"73","first-page":"361","unstructured":null,"article-title":"The first report of macrolide-resistant Bordetella pertussis isolation in Japan","journal-title":"Jpn J Infect Dis","doi-asserted-by":"crossref"},{"DOI":"10.1016/j.ijid.2025.107960","key":"10.1016/j.jiac.2026.102907_bib10","year":"2025","issue":null,"author":"Tsukahara","volume":"158","first-page":"107960","unstructured":null,"article-title":"Severe macrolide-resistant Bordetella pertussis (ptxP3) infection in Japanese infants: first report of cases requiring intensive care","journal-title":"Int J Infect Dis","doi-asserted-by":"crossref"},{"DOI":"10.1016/j.jiac.2025.102727","key":"10.1016/j.jiac.2026.102907_bib11","year":"2025","issue":"7","author":"Iwasaki","volume":"31","first-page":"102727","unstructured":null,"article-title":"Fatal case of macrolide-resistant Bordetella pertussis infection, Japan, 2024","journal-title":"J Infect Chemother","doi-asserted-by":"crossref"},{"DOI":"10.1093/cid/ciw521","key":"10.1016/j.jiac.2026.102907_bib13","year":"2016","issue":"Suppl 4","author":"Nunes","volume":"63","first-page":"S181","unstructured":null,"article-title":"Comparing the yield of nasopharyngeal swabs, nasal aspirates, and induced sputum for detection of Bordetella pertussis in hospitalized infants","journal-title":"Clin Infect Dis","doi-asserted-by":"crossref"},{"DOI":"10.1016/j.jinf.2024.106373","key":"10.1016/j.jiac.2026.102907_bib14","year":"2025","issue":"1","author":"Zhu","volume":"90","first-page":null,"unstructured":null,"article-title":"Resurgence of pertussis in China: evaluating the efficacy of sulfamethoxazole-trimethoprim as an alternative treatment","journal-title":"J Infect","doi-asserted-by":"crossref"},{"DOI":"10.1016/j.jmii.2025.08.023","key":"10.1016/j.jiac.2026.102907_bib15","year":"2025","issue":null,"author":"Wang","volume":null,"first-page":null,"unstructured":null,"article-title":"Levofloxacin is as effective as trimethoprim-sulfamethoxazole for the treatment of pertussis: a prospective observational study","journal-title":"J Microbiol Immunol Infect","doi-asserted-by":"crossref"},{"DOI":"10.1128/JCM.01371-10","key":"10.1016/j.jiac.2026.102907_bib16","year":"2010","issue":"12","author":"Riffelmann","volume":"48","first-page":"4459","unstructured":null,"article-title":"Performance of commercial enzyme-linked immunosorbent assays for detection of antibodies to Bordetella pertussis","journal-title":"J Clin Microbiol","doi-asserted-by":"crossref"},{"DOI":null,"key":"10.1016/j.jiac.2026.102907_bib17","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":"Pharmaceuticals and Medical Devices Agency (PMDA). Prescription drugs information for healthcare professionals: baktar (sulfamethoxazole/trimethoprim). https://www.pmda.go.jp/PmdaSearch/rdSearch/02/6290100F3022?user=1 [accessed 9 October 2025]. [in Japanese)].","article-title":null,"journal-title":null,"doi-asserted-by":null},{"DOI":null,"key":"10.1016/j.jiac.2026.102907_bib18","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":"Medicines and Healthcare products Regulatory Agency (MHRA). Co-trimoxazole for infusion — summary of product characteristics (SmPC). emc. https://www.medicines.org.uk/emc/product/4669/smpc [accessed 9 October 2025].","article-title":null,"journal-title":null,"doi-asserted-by":null},{"DOI":"10.1542/peds.2005-0395","key":"10.1016/j.jiac.2026.102907_bib20","year":"2006","issue":"2","author":"Wennberg","volume":"117","first-page":"474","unstructured":null,"article-title":"Toward understanding kernicterus: a challenge to improve the management of jaundiced newborns","journal-title":"Pediatrics","doi-asserted-by":"crossref"},{"DOI":"10.3109/01480545.2013.834349","key":"10.1016/j.jiac.2026.102907_bib21","year":"2014","issue":"2","author":"Thyagarajan","volume":"37","first-page":"121","unstructured":null,"article-title":"Cotrimoxazole and neonatal kernicterus: a review","journal-title":"Drug Chem Toxicol","doi-asserted-by":"crossref"},{"DOI":null,"key":"10.1016/j.jiac.2026.102907_bib22","year":"2025","issue":null,"author":null,"volume":null,"first-page":"108","unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":null},{"DOI":"10.1016/j.vaccine.2017.05.082","key":"10.1016/j.jiac.2026.102907_bib23","year":"2017","issue":"31","author":"Ikematsu","volume":"35","first-page":"3859","unstructured":null,"article-title":"A cross-sectional survey measuring sero-incidence of pertussis infection among Japanese junior and senior high school students in 2013 and 2014","journal-title":"Vaccine","doi-asserted-by":"crossref"},{"DOI":"10.1016/j.jiac.2019.03.027","key":"10.1016/j.jiac.2026.102907_bib24","year":"2019","issue":"8","author":"Nakayama","volume":"25","first-page":"643","unstructured":null,"article-title":"Vaccine-acquired pertussis immunity was weakened at 4 years of age and asymptomatic pertussis infection was suspected based on serological surveillance","journal-title":"J Infect Chemother","doi-asserted-by":"crossref"},{"DOI":"10.1016/j.vaccine.2020.11.035","key":"10.1016/j.jiac.2026.102907_bib25","year":"2021","issue":"1","author":"Ohfuji","volume":"39","first-page":"11","unstructured":null,"article-title":"Effectiveness of four doses of pertussis vaccine during infancy diminished in elementary school age: a test-negative case-control study in Japan","journal-title":"Vaccine","doi-asserted-by":"crossref"},{"DOI":"10.1001/jamapediatrics.2022.5689","key":"10.1016/j.jiac.2026.102907_bib27","year":"2023","issue":"4","author":"Skoff","volume":"177","first-page":"395","unstructured":null,"article-title":"US infant pertussis incidence trends before and after implementation of the maternal tetanus, diphtheria, and acellular pertussis vaccine","journal-title":"JAMA Pediatr","doi-asserted-by":"crossref"},{"DOI":"10.3390/vaccines10121990","key":"10.1016/j.jiac.2026.102907_bib28","year":"2022","issue":"12","author":"Abu-Raya","volume":"10","first-page":"1990","unstructured":null,"article-title":"Vaccination in pregnancy against pertussis: a consensus statement on behalf of the global pertussis initiative","journal-title":"Vaccines (Basel)","doi-asserted-by":"crossref"},{"DOI":"10.1016/j.vaccine.2018.01.048","key":"10.1016/j.jiac.2026.102907_bib29","year":"2018","issue":"20","author":"Yasui","volume":"36","first-page":"2910","unstructured":null,"article-title":"School-age children and adolescents suspected of having been to be infected with pertussis in Japan","journal-title":"Vaccine","doi-asserted-by":"crossref"}],"short-title":[],"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"update-policy":"https://doi.org/10.1016/elsevier_cm_policy","alternative-id":["S1341321X2600005X"],"article-number":"102907","content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"original-title":[],"container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2026,2]]},"reference-count":23,"published-online":null,"references-count":23,"short-container-title":["Journal of Infection and Chemotherapy"],"is-referenced-by-count":0},"unpaywall":{"doi":"10.1016/j.jiac.2026.102907","is_oa":false,"title":"Microbiologic clearance in macrolide-resistant Bordetella pertussis: An infant treated with sulfamethoxazole-trimethoprim — A case timeline","updated":"2026-01-14T02:41:26+00:00","published_date":"2026-01-09","best_oa_location":null}},"created_at":"2026-01-17T09:03:27.421Z","updated_at":"2026-01-21T12:05:26.220Z","tags":[{"paper_doi":"10.1016/j.jiac.2026.102907","tag_type":"age_group","value":"infant","value_numeric":null},{"paper_doi":"10.1016/j.jiac.2026.102907","tag_type":"category","value":"Infectious Diseases","value_numeric":null},{"paper_doi":"10.1016/j.jiac.2026.102907","tag_type":"condition","value":"Pertussis","value_numeric":null},{"paper_doi":"10.1016/j.jiac.2026.102907","tag_type":"generic","value":"sulfamethoxazole-trimethoprim","value_numeric":null},{"paper_doi":"10.1016/j.jiac.2026.102907","tag_type":"impact_flag","value":"limited_evidence","value_numeric":null},{"paper_doi":"10.1016/j.jiac.2026.102907","tag_type":"level_of_evidence","value":"6","value_numeric":null},{"paper_doi":"10.1016/j.jiac.2026.102907","tag_type":"modality","value":"Antibiotic","value_numeric":null},{"paper_doi":"10.1016/j.jiac.2026.102907","tag_type":"sample_size","value":"n=1","value_numeric":1},{"paper_doi":"10.1016/j.jiac.2026.102907","tag_type":"study_design","value":"Case Report","value_numeric":null},{"paper_doi":"10.1016/j.jiac.2026.102907","tag_type":"warning","value":"Empiric azithromycin was started, so the independent effect of sulfamethoxazole‑trimethoprim cannot be isolated.","value_numeric":null},{"paper_doi":"10.1016/j.jiac.2026.102907","tag_type":"warning","value":"Lower‑airway PCR clearance timing is incomplete because sampling ended after extubation.","value_numeric":null},{"paper_doi":"10.1016/j.jiac.2026.102907","tag_type":"warning","value":"Single-patient case; generalizability is limited.","value_numeric":null}],"summaries":{"what_studied":"A single 6-week-old unvaccinated infant with life-threatening macrolide-resistant Bordetella pertussis (23S rRNA A2047G) treated with a 14-day course of sulfamethoxazole‑trimethoprim after empiric azithromycin. Daily nasopharyngeal and lower-airway microbiology (Gram stain, culture, quantitative PCR) tracked clearance.","key_result":"Nasopharyngeal cultures turned negative by Day 2 of sulfamethoxazole‑trimethoprim; lower‑airway aspirate cultures by Day 3. Nasopharyngeal qPCR fell below detection by Day 7, while lower‑airway qPCR declined through Day 7; the infant recovered without sequelae.","limitations":"Single case with no comparator. Empiric azithromycin was given alongside sulfamethoxazole‑trimethoprim, clouding attribution. Lower‑airway qPCR sampling stopped after extubation, so time to PCR negativity is unknown.","practice_takeaway":"In macrolide‑resistant pertussis, sulfamethoxazole‑trimethoprim may achieve bacteriologic clearance within a few days, aligning with the common five‑day window used to end precautions after effective therapy."}},{"doi":"10.1001/jamanetworkopen.2025.53179","pmid":"41505127","title":"Maternal Vaccine Receipt and Infant Hospital and Emergency Visits for Influenza and Pertussis","journal_title":"JAMA Network Open","journal_issn":"2574-3805","published_at":"2026-01-08T00:00:00.000Z","url":"https://doi.org/10.1001/jamanetworkopen.2025.53179","source_score":94,"is_retracted":false,"is_open_access":true,"raw_metadata":{"ooir":{"day":"2026-01-11","doi":"10.1001/jamanetworkopen.2025.53179","days":"7","issn":"2574-3805","rank":"10","field":"Clinical Medicine","score":"94","category":"Medicine, General & Internal","categories":["Medicine, General & Internal"],"_categories":["Medicine, General & Internal"]},"pubmed":{"doi":"10.1001/jamanetworkopen.2025.53179","title":"Maternal Vaccine Receipt and Infant Hospital and Emergency Visits for Influenza and Pertussis.","journal":"JAMA network open","methods":"","results":"This study included 53 448 pregnant individuals who received the Tdap vaccine and 5347 who received influenza vaccine. The maternal vaccination coverage (ie, proportion of vaccinated pregnant individuals among those eligible) was 5359 (6.4%) for influenza and 70 119 (41.0%) for Tdap, respectively. Infants born to mothers who received the influenza and Tdap vaccine had a lower risk of hospitalization or ED visit for influenza (VE, 69.7%; 95% CI, 8.7%-90.0%) and pertussis (VE, 88.6%; 95% CI, 11.5%-98.5%), respectively.","abstract":"$31","keywords":[],"pubmed_id":"41505127","conclusions":"","publication_date":"2026-01-08T00:00:00"},"crossref":{"DOI":"10.1001/jamanetworkopen.2025.53179","URL":"https://doi.org/10.1001/jamanetworkopen.2025.53179","ISSN":["2574-3805"],"link":[{"URL":"https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2843534/morabito_2026_oi_251415_1767025234.26717.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"page":"e2553179","type":"journal-article","issue":"1","score":1,"title":["Maternal Vaccine Receipt and Infant Hospital and Emergency Visits for Influenza and Pertussis"],"author":[{"given":"Gabriella","family":"Morabito","sequence":"first","affiliation":[{"name":"National Centre for Healthcare Research and Pharmacoepidemiology, at the University of Milano-Bicocca Milan, Italy"},{"name":"Laboratory of Healthcare Research and Pharmacoepidemiology, Unit of Biostatistics, Epidemiology and Public Health, Department of Statistics and Quantitative Methods, University of Milano-Bicocca, Milan, Italy"}]},{"given":"Giovanni","family":"Corrao","sequence":"additional","affiliation":[{"name":"University of Milano-Bicocca (Emeritus Professor), Milan, Italy"}]},{"given":"Carlo","family":"Giaquinto","sequence":"additional","affiliation":[{"name":"Department for Women’s and Children’s Health, University of Padua, Padua, Italy"}]},{"given":"Anna","family":"Cantarutti","sequence":"additional","affiliation":[{"name":"National Centre for Healthcare Research and Pharmacoepidemiology, at the University of Milano-Bicocca Milan, Italy"},{"name":"Laboratory of Healthcare Research and Pharmacoepidemiology, Unit of Biostatistics, Epidemiology and Public Health, Department of Statistics and Quantitative Methods, University of Milano-Bicocca, Milan, Italy"}]},{"given":"Costanza","family":"Di Chiara","sequence":"additional","affiliation":[{"name":"Department for Women’s and Children’s Health, University of Padua, Padua, Italy"}]}],"issued":{"date-parts":[[2026,1,8]]},"member":"10","prefix":"10.1001","source":"Crossref","volume":"9","created":{"date-time":"2026-01-08T16:00:45Z","timestamp":1767888045000,"date-parts":[[2026,1,8]]},"indexed":{"date-time":"2026-01-08T20:31:43Z","timestamp":1767904303123,"date-parts":[[2026,1,8]]},"subject":[],"abstract":"$32","language":"en","relation":{},"resource":{"primary":{"URL":"https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2843534"}},"subtitle":[],"deposited":{"date-time":"2026-01-08T16:00:47Z","timestamp":1767888047000,"date-parts":[[2026,1,8]]},"issn-type":[{"type":"electronic","value":"2574-3805"}],"published":{"date-parts":[[2026,1,8]]},"publisher":"American Medical Association (AMA)","reference":[{"DOI":"10.1097/INF.0000000000001440","key":"zoi251415r1","year":"2017","issue":"3","author":"Masseria","volume":"36","first-page":"e54","unstructured":null,"article-title":"Incidence and burden of pertussis among infants less than 1 year of age.","journal-title":"Pediatr Infect Dis J","doi-asserted-by":"publisher"},{"DOI":"10.1016/S2214-109X(19)30545-5","key":"zoi251415r2","year":"2020","issue":"4","author":"Wang","volume":"8","first-page":"e497","unstructured":null,"article-title":"Global burden of respiratory infections associated with seasonal influenza in children under 5 years in 2018: a systematic review and modelling study.","journal-title":"Lancet Glob Health","doi-asserted-by":"publisher"},{"DOI":"10.1016/j.pcl.2022.11.004","key":"zoi251415r3","year":"2023","issue":"2","author":"Rand","volume":"70","first-page":"259","unstructured":null,"article-title":"Maternal vaccination and vaccine hesitancy.","journal-title":"Pediatr Clin North Am","doi-asserted-by":"publisher"},{"DOI":"10.1056/NEJMc0912599","key":"zoi251415r4","year":"2010","issue":"17","author":"Steinhoff","volume":"362","first-page":"1644","unstructured":null,"article-title":"Influenza immunization in pregnancy-antibody responses in mothers and infants.","journal-title":"N Engl J Med","doi-asserted-by":"publisher"},{"DOI":"10.1016/j.ajog.2010.11.024","key":"zoi251415r5","year":"2011","issue":"4","author":"Gall","volume":"204","first-page":"334.e1","unstructured":null,"article-title":"Maternal immunization with tetanus-diphtheria-pertussis vaccine: effect on maternal and neonatal serum antibody levels.","journal-title":"Am J Obstet Gynecol","doi-asserted-by":"publisher"},{"DOI":"10.1016/j.vaccine.2020.07.014","key":"zoi251415r6","year":"2020","issue":"52","author":"Mazagatos","volume":"38","first-page":"8405","unstructured":null,"article-title":"Effectiveness of influenza vaccination during pregnancy to prevent severe infection in children under 6 months of age, Spain, 2017-2019.","journal-title":"Vaccine","doi-asserted-by":"publisher"},{"DOI":"10.1093/infdis/jix629","key":"zoi251415r7","year":"2018","issue":"6","author":"Ohfuji","volume":"217","first-page":"878","unstructured":null,"article-title":"Protective effect of maternal influenza vaccination on influenza in their infants: a prospective cohort study.","journal-title":"J Infect Dis","doi-asserted-by":"publisher"},{"DOI":"10.1016/j.vaccine.2019.12.056","key":"zoi251415r8","year":"2020","issue":"7","author":"Jarvis","volume":"38","first-page":"1601","unstructured":null,"article-title":"The effectiveness of influenza vaccination in pregnancy in relation to child health outcomes: systematic review and meta-analysis.","journal-title":"Vaccine","doi-asserted-by":"publisher"},{"DOI":"10.1542/peds.2021-051076","key":"zoi251415r9","year":"2021","issue":"3","author":"Rowe","volume":"148","first-page":null,"unstructured":null,"article-title":"Maternal vaccination and infant influenza and pertussis.","journal-title":"Pediatrics","doi-asserted-by":"publisher"},{"DOI":"10.1001/jamapediatrics.2023.5639","key":"zoi251415r10","year":"2024","issue":"2","author":"Sahni","volume":"178","first-page":"176","unstructured":null,"article-title":"Maternal vaccine effectiveness against influenza-associated hospitalizations and emergency department visits in infants.","journal-title":"JAMA Pediatr","doi-asserted-by":"publisher"},{"DOI":"10.1186/s12879-020-4824-3","key":"zoi251415r11","year":"2020","issue":"1","author":"Vygen-Bonnet","volume":"20","first-page":"136","unstructured":null,"article-title":"Safety and effectiveness of acellular pertussis vaccination during pregnancy: a systematic review.","journal-title":"BMC Infect Dis","doi-asserted-by":"publisher"},{"DOI":"10.3390/vaccines9101107","key":"zoi251415r13","year":"2021","issue":"10","author":"Cavaliere","volume":"9","first-page":"1107","unstructured":null,"article-title":"Flu and Tdap maternal immunization hesitancy in times of COVID-19: an Italian survey on multiethnic sample.","journal-title":"Vaccines (Basel)","doi-asserted-by":"publisher"},{"DOI":"10.1038/s41598-022-11308-3","key":"zoi251415r14","year":"2022","issue":"1","author":"Corbeau","volume":"12","first-page":"7153","unstructured":null,"article-title":"Trends of influenza vaccination coverage in pregnant women: a ten-year analysis from a French healthcare database.","journal-title":"Sci Rep","doi-asserted-by":"publisher"},{"DOI":"10.3390/ijerph182312621","key":"zoi251415r15","year":"2021","issue":"23","author":"Cantarutti","volume":"18","first-page":"12621","unstructured":null,"article-title":"Use of antibiotic treatment in pregnancy and the risk of several neonatal outcomes: a population-based study.","journal-title":"Int J Environ Res Public Health","doi-asserted-by":"publisher"},{"DOI":"10.1016/j.jad.2023.07.066","key":"zoi251415r16","year":"2023","issue":null,"author":"Lupattelli","volume":"339","first-page":"502","unstructured":null,"article-title":"Antidepressant continuation and adherence in pregnancy, and risk of antenatal hospitalization for unipolar major depressive and/or anxiety disorders.","journal-title":"J Affect Disord","doi-asserted-by":"publisher"},{"DOI":"10.1016/S0140-6736(07)61602-X","key":"zoi251415r18","year":"2007","issue":"9596","author":"von Elm","volume":"370","first-page":"1453","unstructured":null,"article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.","journal-title":"Lancet","doi-asserted-by":"publisher"},{"DOI":"10.1002/sim.3697","key":"zoi251415r19","year":"2009","issue":"25","author":"Austin","volume":"28","first-page":"3083","unstructured":null,"article-title":"Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples.","journal-title":"Stat Med","doi-asserted-by":"publisher"},{"DOI":"10.1161/CIRCULATIONAHA.115.017719","key":"zoi251415r20","year":"2016","issue":"6","author":"Austin","volume":"133","first-page":"601","unstructured":null,"article-title":"Introduction to the analysis of survival data in the presence of competing risks.","journal-title":"Circulation","doi-asserted-by":"publisher"},{"DOI":"10.1093/biomet/80.3.557","key":"zoi251415r21","year":"1993","issue":"3","author":"Lin","volume":"80","first-page":"557","unstructured":null,"article-title":"Checking the Cox Model with cumulative sums of martingale-based residuals.","journal-title":"Biometrika","doi-asserted-by":"publisher"},{"DOI":"10.1086/657309","key":"zoi251415r22","year":"2010","issue":"12","author":"Benowitz","volume":"51","first-page":"1355","unstructured":null,"article-title":"Influenza vaccine given to pregnant women reduces hospitalization due to influenza in their infants.","journal-title":"Clin Infect Dis","doi-asserted-by":"publisher"},{"DOI":"10.2807/1560-7917.ES2014.19.45.20959","key":"zoi251415r23","year":"2014","issue":"45","author":"Dabrera","volume":"19","first-page":"20959","unstructured":null,"article-title":"Effectiveness of seasonal influenza vaccination during pregnancy in preventing influenza infection in infants, England, 2013/14.","journal-title":"Euro Surveill","doi-asserted-by":"publisher"},{"DOI":"10.1542/peds.2015-2360","key":"zoi251415r24","year":"2016","issue":"6","author":"Shakib","volume":"137","first-page":null,"unstructured":null,"article-title":"Influenza in infants born to women vaccinated during pregnancy.","journal-title":"Pediatrics","doi-asserted-by":"publisher"},{"DOI":"10.1016/j.amepre.2018.04.013","key":"zoi251415r25","year":"2018","issue":"2","author":"Becker-Dreps","volume":"55","first-page":"159","unstructured":null,"article-title":"Effectiveness of Prenatal tetanus, diphtheria, acellular pertussis vaccination in the prevention of infant pertussis in the US.","journal-title":"Am J Prev Med","doi-asserted-by":"publisher"},{"DOI":"10.1016/j.vaccine.2018.02.047","key":"zoi251415r26","year":"2018","issue":"14","author":"Saul","volume":"36","first-page":"1887","unstructured":null,"article-title":"Effectiveness of maternal pertussis vaccination in preventing infection and disease in infants: the NSW Public Health Network case-control study.","journal-title":"Vaccine","doi-asserted-by":"publisher"},{"DOI":"10.1002/ijgo.14797","key":"zoi251415r27","year":"2023","issue":"1","author":"Ferrari","volume":"162","first-page":"105","unstructured":null,"article-title":"Pregnancy vaccination predictive factors and uptake profiles among Italian women: a cross-sectional survey study on a large population.","journal-title":"Int J Gynaecol Obstet","doi-asserted-by":"publisher"},{"DOI":null,"key":"zoi251415r12","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":"Piano Nazionale Prevenzione Vaccinale 2017-2019 [National Plan for Vaccine Prevention 2017-19]. Ministero della Salute. Accessed December 12, 2024. https://www.salute.gov.it/imgs/C_17_pubblicazioni_2571_allegato.pdf","article-title":null,"journal-title":null,"doi-asserted-by":null},{"DOI":null,"key":"zoi251415r17","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":"Linee guida per la classificazione e conduzione degli studi osservazionali sui farmaci. Agenzia Italiana Del Farmaco. Accessed December 11, 2024. https://www.aifa.gov.it/documents/20142/0/DETERMINAZ_AIFA_20_Marzo_2008_ST_OSS.pdf","article-title":null,"journal-title":null,"doi-asserted-by":null},{"DOI":null,"key":"zoi251415r28","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":"National reports on medicines use in Italy year 2019. Italian Medicines Agency. Accessed December 13, 2024. https://www.aifa.gov.it/documents/20142/241052/OsMed_2019_Eng.pdf","article-title":null,"journal-title":null,"doi-asserted-by":null}],"short-title":[],"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1,2]]}},"content-domain":{"domain":[],"crossmark-restriction":false},"original-title":[],"container-title":["JAMA Network Open"],"reference-count":28,"published-online":{"date-time":null,"timestamp":null,"date-parts":[[2026,1,8]]},"references-count":28,"short-container-title":["JAMA Netw Open"],"is-referenced-by-count":0},"unpaywall":{"doi":"10.1001/jamanetworkopen.2025.53179","is_oa":true,"title":"Maternal Vaccine Receipt and Infant Hospital and Emergency Visits for Influenza and Pertussis","updated":"2026-01-13T16:36:47+00:00","published_date":"2026-01-08","best_oa_location":{"url":"https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2843534/morabito_2026_oi_251415_1767025234.26717.pdf","pmh_id":null,"url_for_pdf":"https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2843534/morabito_2026_oi_251415_1767025234.26717.pdf","url_for_landing_page":"https://doi.org/10.1001/jamanetworkopen.2025.53179"}}},"created_at":"2026-01-18T22:40:12.285Z","updated_at":"2026-01-18T22:40:12.285Z","tags":[{"paper_doi":"10.1001/jamanetworkopen.2025.53179","tag_type":"age_group","value":"infant","value_numeric":null},{"paper_doi":"10.1001/jamanetworkopen.2025.53179","tag_type":"category","value":"Medicine, General & Internal","value_numeric":null},{"paper_doi":"10.1001/jamanetworkopen.2025.53179","tag_type":"condition","value":"Influenza","value_numeric":null},{"paper_doi":"10.1001/jamanetworkopen.2025.53179","tag_type":"condition","value":"Pertussis","value_numeric":null},{"paper_doi":"10.1001/jamanetworkopen.2025.53179","tag_type":"level_of_evidence","value":"3","value_numeric":null},{"paper_doi":"10.1001/jamanetworkopen.2025.53179","tag_type":"modality","value":"Vaccine","value_numeric":null},{"paper_doi":"10.1001/jamanetworkopen.2025.53179","tag_type":"study_design","value":"Cohort Study","value_numeric":null},{"paper_doi":"10.1001/jamanetworkopen.2025.53179","tag_type":"warning","value":"Absolute event counts and follow-up duration are not provided in the excerpt.","value_numeric":null},{"paper_doi":"10.1001/jamanetworkopen.2025.53179","tag_type":"warning","value":"Total cohort size including matched unvaccinated comparators is not reported.","value_numeric":null},{"paper_doi":"10.1001/jamanetworkopen.2025.53179","tag_type":"warning","value":"Vaccinated counts included differ from reported coverage figures (e.g., Tdap 53,448 included vs 70,119 coverage), suggesting different denominators.","value_numeric":null}],"summaries":{"what_studied":"A population-based matched cohort in Lombardy, Italy (births 2018–2022) assessed whether maternal influenza or Tdap vaccination during pregnancy was associated with infant (<6 months) hospitalizations or ED visits for influenza or pertussis. Vaccinated mothers were matched to unvaccinated mothers by delivery month/year, gestational age, and multiplicity.","key_result":"Maternal influenza vaccination was associated with 69.7% vaccine effectiveness against infant hospitalization/ED visits for influenza (95% CI, 8.7%–90.0%), and maternal Tdap with 88.6% effectiveness against pertussis (95% CI, 11.5%–98.5%).","practice_takeaway":"Maternal influenza and Tdap vaccination during pregnancy were associated with fewer influenza- and pertussis-related hospital or ED visits in infants under 6 months. Low coverage (influenza 6.4%; Tdap 41.0%) highlights the need to improve uptake in prenatal care."}},{"doi":"10.1016/j.ijid.2025.108194","pmid":"41207370","title":"Incidence of Respiratory Infections after the COVID-19 Pandemic (2023–2024) and Its Association of Vaccination Among Entire Populations in Korea","journal_title":"International Journal of Infectious Diseases","journal_issn":"1201-9712","published_at":"2025-11-10T00:00:00.000Z","url":"https://doi.org/10.1016/j.ijid.2025.108194","source_score":387,"is_retracted":false,"is_open_access":true,"raw_metadata":{"ooir":{"day":"2025-11-08","doi":"10.1016/j.ijid.2025.108194","days":"30","issn":"1201-9712","rank":"1","field":"Clinical Medicine","score":"387","category":"Infectious Diseases","categories":["Infectious Diseases"],"_categories":["Infectious Diseases"]},"pubmed":{"doi":"10.1016/j.ijid.2025.108194","title":"Incidence of Respiratory Infections after the COVID-19 Pandemic (2023-2024) and Its Association of Vaccination Among Entire Populations in Korea.","journal":"International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases","methods":"","results":"","abstract":"Objectives We aimed to investigate nationwide trends in respiratory infections during and after the COVID-19 pandemic and to evaluate the risk according to the COVID-19 vaccine dose. Methods Using the database, which integrates the insurance claims and vaccination records for the entire Korean population (N=51,645,564), trends were assessed using SARIMAX models. We assessed associations between the doses that have been received until June 1, 2023, and the onset of respiratory infections, using Cox hazard and Fine-Gray models. Results Compared with pre-pandemic levels (2017-2019), influenza like illness (ILI) and pneumonia incidences dropped by over 90% during 2020-2021, followed by a resurgence of upper respiratory tract infection (URI) and common cold in 2023-2024. Pertussis incidence rose 46-fold above expected levels in late 2023. Individuals (≥4","keywords":["COVID-19 vaccine","Post-COVID","respiratory infectious diseases"],"pubmed_id":"41207370","conclusions":"","publication_date":"2025-11-10T00:00:00"},"crossref":{"DOI":"10.1016/j.ijid.2025.108194","URL":"https://doi.org/10.1016/j.ijid.2025.108194","ISSN":["1201-9712"],"link":[{"URL":"https://api.elsevier.com/content/article/PII:S1201971225004163?httpAccept=text/xml","content-type":"text/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https://api.elsevier.com/content/article/PII:S1201971225004163?httpAccept=text/plain","content-type":"text/plain","content-version":"vor","intended-application":"text-mining"}],"page":"108194","type":"journal-article","issue":null,"score":1,"title":["Incidence of Respiratory Infections after the COVID-19 Pandemic (2023–2024) and Its Association of Vaccination Among Entire Populations in Korea"],"author":[{"given":"Jihun","family":"Song","sequence":"first","affiliation":[]},{"given":"Seogsong","family":"Jeong","sequence":"additional","affiliation":[]},{"given":"Asaph Young","family":"Chun","sequence":"additional","affiliation":[]},{"given":"Jaehun","family":"Jung","sequence":"additional","affiliation":[]},{"given":"Sun Jae","family":"Park","sequence":"additional","affiliation":[]},{"given":"Sang Min","family":"Park","sequence":"additional","affiliation":[]}],"funder":[{"id":[{"id":"10.13039/501100003725","id-type":"DOI","asserted-by":"publisher"}],"DOI":"10.13039/501100003725","name":"National Research Foundation of Korea","award":["NRF-2022R1A2C2092076","RS-2023-00227944"],"doi-asserted-by":"publisher"}],"issued":{"date-parts":[[2025,11]]},"member":"78","prefix":"10.1016","source":"Crossref","volume":null,"created":{"date-time":"2025-11-08T02:02:18Z","timestamp":1762567338000,"date-parts":[[2025,11,8]]},"indexed":{"date-time":"2025-11-21T16:36:45Z","timestamp":1763743005580,"date-parts":[[2025,11,21]]},"license":[{"URL":"https://www.elsevier.com/tdm/userlicense/1.0/","start":{"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000,"date-parts":[[2025,11,1]]},"delay-in-days":0,"content-version":"tdm"},{"URL":"https://www.elsevier.com/legal/tdmrep-license","start":{"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000,"date-parts":[[2025,11,1]]},"delay-in-days":0,"content-version":"tdm"},{"URL":"http://creativecommons.org/licenses/by-nc-nd/4.0/","start":{"date-time":"2025-11-05T00:00:00Z","timestamp":1762300800000,"date-parts":[[2025,11,5]]},"delay-in-days":4,"content-version":"vor"}],"subject":[],"abstract":null,"language":"en","relation":{},"resource":{"primary":{"URL":"https://linkinghub.elsevier.com/retrieve/pii/S1201971225004163"}},"subtitle":[],"assertion":[{"name":"publisher","label":"This article is maintained by","value":"Elsevier"},{"name":"articletitle","label":"Article Title","value":"Incidence of Respiratory Infections after the COVID-19 Pandemic (2023–2024) and Its Association of Vaccination Among Entire Populations in Korea"},{"name":"journaltitle","label":"Journal Title","value":"International Journal of Infectious Diseases"},{"name":"articlelink","label":"CrossRef DOI link to publisher maintained version","value":"https://doi.org/10.1016/j.ijid.2025.108194"},{"name":"content_type","label":"Content Type","value":"article"},{"name":"copyright","label":"Copyright","value":"© 2025 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases."}],"deposited":{"date-time":"2025-11-21T16:33:24Z","timestamp":1763742804000,"date-parts":[[2025,11,21]]},"issn-type":[{"type":"print","value":"1201-9712"}],"published":{"date-parts":[[2025,11]]},"publisher":"Elsevier BV","reference":[{"DOI":null,"key":"10.1016/j.ijid.2025.108194_bib0001","year":"2022","issue":"1","author":"Liu","volume":"8","first-page":"21","unstructured":null,"article-title":"Market, Complexity. Open innovation in times of crisis: An overview of the healthcare sector in response to the COVID-19 Pandemic","journal-title":"JJoOIT","doi-asserted-by":null},{"DOI":null,"key":"10.1016/j.ijid.2025.108194_bib0002","year":"2022","issue":null,"author":"Tuczyńska","volume":"10","first-page":null,"unstructured":null,"article-title":"Quality of the healthcare services during COVID-19 pandemic in selected European countries","journal-title":"JFiph","doi-asserted-by":null},{"DOI":null,"key":"10.1016/j.ijid.2025.108194_bib0003","year":"2022","issue":"4","author":"Smolić","volume":"19","first-page":"793","unstructured":null,"article-title":"Access to healthcare for people aged 50+ in Europe during the COVID-19 outbreak","journal-title":"JEJoA","doi-asserted-by":null},{"DOI":null,"key":"10.1016/j.ijid.2025.108194_bib0004","year":"2022","issue":"1","author":"Troisi","volume":"22","first-page":"1096","unstructured":null,"article-title":"The other side of the crisis: organizational flexibility in balancing Covid-19 and non-Covid-19 health-care services","journal-title":"JBHSR","doi-asserted-by":null},{"DOI":null,"key":"10.1016/j.ijid.2025.108194_bib0005","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":"Flaxman S, Mishra S, Gandy A, Unwin HJT, Mellan TA, Coupland H, et al. Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe. 2020;584(7820):257–61.","article-title":null,"journal-title":null,"doi-asserted-by":null},{"DOI":"10.1016/S1473-3099(20)30982-8","key":"10.1016/j.ijid.2025.108194_bib0006","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":"Spinelli MA, Glidden DV, Gennatas ED, Bielecki M, Beyrer C, Rutherford G, et al. Importance of non-pharmaceutical interventions in lowering the viral inoculum to reduce susceptibility to infection by SARS-CoV-2 and potentially disease severity. 2021;21(9):e296–e301.","article-title":null,"journal-title":null,"doi-asserted-by":"crossref"},{"DOI":null,"key":"10.1016/j.ijid.2025.108194_bib0007","year":"2020","issue":"48","author":"Baker","volume":"117","first-page":"30547","unstructured":null,"article-title":"The impact of COVID-19 nonpharmaceutical interventions on the future dynamics of endemic infections","journal-title":"JPotNAoS","doi-asserted-by":null},{"DOI":null,"key":"10.1016/j.ijid.2025.108194_bib0008","year":"2022","issue":"8","author":"Kang","volume":"15","first-page":"915","unstructured":null,"article-title":"The impact of the COVID-19 pandemic in the healthcare utilization in Korea: Analysis of a nationwide survey","journal-title":"JJoI, Health P.","doi-asserted-by":null},{"DOI":null,"key":"10.1016/j.ijid.2025.108194_bib0009","year":"2020","issue":null,"author":"Olsen","volume":"2020","first-page":"69","unstructured":null,"article-title":"Decreased influenza activity during the covid-19 pandemic—United States, Australia, Chile, and South Africa","journal-title":"JJMM, report mw","doi-asserted-by":null},{"DOI":null,"key":"10.1016/j.ijid.2025.108194_bib0010","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":"Brueggemann AB, van Rensburg MJJ, Shaw D, McCarthy ND, Jolley KA, Maiden MC, et al. Changes in the incidence of invasive disease due to Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis during the COVID-19 pandemic in 26 countries and territories in the Invasive Respiratory Infection Surveillance Initiative: a prospective analysis of surveillance data. 2021;3(6):e360–e70.","article-title":null,"journal-title":null,"doi-asserted-by":null},{"DOI":"10.2807/1560-7917.ES.2021.26.29.2001600","key":"10.1016/j.ijid.2025.108194_bib0011","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":"Tempia S, Walaza S, Bhiman JN, McMorrow ML, Moyes J, Mkhencele T, et al. Decline of influenza and respiratory syncytial virus detection in facility-based surveillance during the COVID-19 pandemic, South Africa, January to October 2020. 2021;26(29):2001600.","article-title":null,"journal-title":null,"doi-asserted-by":"crossref"},{"DOI":null,"key":"10.1016/j.ijid.2025.108194_bib0012","year":"2023","issue":"3","author":"Chow","volume":"21","first-page":"195","unstructured":null,"article-title":"The effects of the COVID-19 pandemic on community respiratory virus activity","journal-title":"JNRM","doi-asserted-by":null},{"DOI":"10.3390/life14060742","key":"10.1016/j.ijid.2025.108194_bib0013","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":"Kalopitas G, Arvanitakis K, Tsachouridou O, Malandris K, Koufakis T, Metallidis S, et al. Metabolic Dysfunction-Associated Steatotic Liver Disease in People Living with HIV—Limitations on Antiretroviral Therapy Selection. 2024;14(6):742.","article-title":null,"journal-title":null,"doi-asserted-by":"crossref"},{"DOI":"10.1038/s41467-024-48825-w","key":"10.1016/j.ijid.2025.108194_bib0014","year":"2024","issue":"1","author":"Choi","volume":"15","first-page":"4499","unstructured":null,"article-title":"Acute and post-acute respiratory complications of SARS-CoV-2 infection: population-based cohort study in South Korea and Japan","journal-title":"Nature Communications","doi-asserted-by":"crossref"},{"DOI":"10.1016/j.idnow.2021.05.004","key":"10.1016/j.ijid.2025.108194_bib0015","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":"Cohen R, Ashman M, Taha M-K, Varon E, Angoulvant F, Levy C, et al. Pediatric Infectious Disease Group (GPIP) position paper on the immune debt of the COVID-19 pandemic in childhood, how can we fill the immunity gap? 2021;51(5):418–23.","article-title":null,"journal-title":null,"doi-asserted-by":"crossref"},{"DOI":null,"key":"10.1016/j.ijid.2025.108194_bib0016","year":"2021","issue":null,"author":"Lee","volume":"144","first-page":null,"unstructured":null,"article-title":"Comparing the diagnostic accuracy of rapid antigen detection tests to real time polymerase chain reaction in the diagnosis of SARS-CoV-2 infection: A systematic review and meta-analysis","journal-title":"JJoCV","doi-asserted-by":null},{"DOI":null,"key":"10.1016/j.ijid.2025.108194_bib0017","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":"Lee H, Choi S, Eom E, Song GH, Kim SS. Introduction to the Research Results of Coronavirus Disease 2019 Big Data (K-COV-N) and the Corresponding Utilization Plan. 2024.","article-title":null,"journal-title":null,"doi-asserted-by":null},{"DOI":"10.1080/21505594.2025.2480633","key":"10.1016/j.ijid.2025.108194_bib0018","year":"2025","issue":"1","author":"Alizon","volume":"16","first-page":null,"unstructured":null,"article-title":"SARS-CoV-2 epidemiology, kinetics, and evolution: A narrative review","journal-title":"Virulence","doi-asserted-by":"crossref"},{"DOI":"10.1038/s41579-023-00878-2","key":"10.1016/j.ijid.2025.108194_bib0019","year":"2023","issue":"6","author":"Markov","volume":"21","first-page":"361","unstructured":null,"article-title":"The evolution of SARS-CoV-2","journal-title":"Nature Reviews Microbiology","doi-asserted-by":"crossref"},{"DOI":null,"key":"10.1016/j.ijid.2025.108194_bib0020","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":"Organization WH. Clinical management of COVID-19: living guideline, 18 August 2023. Clinical management of COVID-19: living guideline, 18 August 2023, 2023.","article-title":null,"journal-title":null,"doi-asserted-by":null},{"DOI":"10.1002/rmv.2146","key":"10.1016/j.ijid.2025.108194_bib0021","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":"Gallo Marin B, Aghagoli G, Lavine K, Yang L, Siff EJ, Chiang SS, et al. Predictors of COVID-19 severity: a literature review. 2021;31(1):1–10.","article-title":null,"journal-title":null,"doi-asserted-by":"crossref"},{"DOI":"10.3342/kjorl-hns.2022.00101","key":"10.1016/j.ijid.2025.108194_bib0022","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":"Kim JY, Kim SH, Choi H, Yang HJ, Hong MJ, Lim Y-S, et al. Incidence of upper respiratory diseases during the COVID-19 pandemic: a nationwide data-based epidemiological study. 2023;66(3):162–9.","article-title":null,"journal-title":null,"doi-asserted-by":"crossref"},{"DOI":"10.1017/S0950268807008564","key":"10.1016/j.ijid.2025.108194_bib0023","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":"Skull SA, Andrews RM, Byrnes GB, Campbell DA, Nolan TM, Brown GV, et al. ICD-10 codes are a valid tool for identification of pneumonia in hospitalized patients aged⩾ 65 years. 2008;136(2):232–40.","article-title":null,"journal-title":null,"doi-asserted-by":"crossref"},{"DOI":"10.1080/22221751.2022.2164215","key":"10.1016/j.ijid.2025.108194_bib0024","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":"Hwang J-H, You YS, Yeom SW, Lee MG, Lee J-h, Kim MG, et al. Influenza viral infection is a risk factor for severe illness in COVID-19 patients: a nationwide population-based cohort study. 2023;12(1):2164215.","article-title":null,"journal-title":null,"doi-asserted-by":"crossref"},{"DOI":null,"key":"10.1016/j.ijid.2025.108194_bib0025","year":"2020","issue":"7","author":"Kim","volume":"15","first-page":null,"unstructured":null,"article-title":"Association of adenotonsillectomy with asthma and upper respiratory infection: A nationwide cohort study","journal-title":"JPo.","doi-asserted-by":null},{"DOI":null,"key":"10.1016/j.ijid.2025.108194_bib0026","year":"2024","issue":null,"author":"Phakey","volume":"152","first-page":"e116","unstructured":null,"article-title":"Epidemiology of scarlet fever in Victoria, Australia, 2007–2017","journal-title":"JE, Infection","doi-asserted-by":null},{"DOI":"10.1007/s40121-022-00747-0","key":"10.1016/j.ijid.2025.108194_bib0027","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":"Kim H, Shin J-Y, Chen J, Kim JH, Noh Y, Cheong HJ, et al. Risk Factors of Pertussis Among Older Adults in South Korea: A Nationwide Health Data-Based Case–Control Study. 2023;12(2):545–61.","article-title":null,"journal-title":null,"doi-asserted-by":"crossref"},{"DOI":"10.3961/jpmph.21.635","key":"10.1016/j.ijid.2025.108194_bib0028","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":"Jeong D, Kang H-Y, Kim J, Lee H, Yoo B-N, Kim H-S, et al. Cohort profile: Korean tuberculosis and post-tuberculosis cohort constructed by linking the Korean national tuberculosis surveillance system and national health information database. 2022;55(3):253.","article-title":null,"journal-title":null,"doi-asserted-by":"crossref"},{"DOI":null,"key":"10.1016/j.ijid.2025.108194_bib0029","year":"2023","issue":null,"author":"Jung","volume":"14","first-page":null,"unstructured":null,"article-title":"Association between COVID-19 and incidence of cardiovascular disease and all-cause mortality among patients with diabetes","journal-title":"JFiE","doi-asserted-by":null},{"DOI":"10.1093/cid/ciab311","key":"10.1016/j.ijid.2025.108194_bib0030","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":"Rodgers L, Sheppard M, Smith A, Dietz S, Jayanthi P, Yuan Y, et al. Changes in seasonal respiratory illnesses in the United States during the coronavirus disease 2019 (COVID-19) pandemic. 2021;73(Supplement_1):S110–S7.","article-title":null,"journal-title":null,"doi-asserted-by":"crossref"},{"DOI":"10.1128/spectrum.01161-24","key":"10.1016/j.ijid.2025.108194_bib0031","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":"Zhao P, Zhang Y, Wang J, Li Y, Wang Y, Gao Y, et al. Epidemiology of respiratory pathogens in patients with acute respiratory infections during the COVID-19 pandemic and after easing of COVID-19 restrictions. 2024;12(11):e01161–24.","article-title":null,"journal-title":null,"doi-asserted-by":"crossref"},{"DOI":null,"key":"10.1016/j.ijid.2025.108194_bib0032","year":"2020","issue":"19","author":"Sakamoto","volume":"323","first-page":"1969","unstructured":null,"article-title":"Seasonal influenza activity during the SARS-CoV-2 outbreak in Japan","journal-title":"JJ","doi-asserted-by":null},{"DOI":"10.1016/S2352-4642(20)30307-2","key":"10.1016/j.ijid.2025.108194_bib0033","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":"Britton PN, Hu N, Saravanos G, Shrapnel J, Davis J, Snelling T, et al. COVID-19 public health measures and respiratory syncytial virus. 2020;4(11):e42–e3.","article-title":null,"journal-title":null,"doi-asserted-by":"crossref"},{"DOI":null,"key":"10.1016/j.ijid.2025.108194_bib0034","year":"2022","issue":"9","author":"Arunmozhi","volume":"39","first-page":"2184","unstructured":null,"article-title":"Managing the resource allocation for the COVID-19 pandemic in healthcare institutions: a pluralistic perspective","journal-title":"JIJoQ","doi-asserted-by":null},{"DOI":"10.1016/j.jpeds.2024.114420","key":"10.1016/j.ijid.2025.108194_bib0035","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":"Lenglart L, Titomanlio L, Bognar Z, Bressan S, Buonsenso D, De T, et al. Surge of Pediatric Respiratory Tract Infections After the COVID-19 Pandemic and the Concept of “Immune Debt”. 2024:114420.","article-title":null,"journal-title":null,"doi-asserted-by":"crossref"},{"DOI":null,"key":"10.1016/j.ijid.2025.108194_bib0036","year":"2023","issue":"6","author":"Li","volume":"17","first-page":"499","unstructured":null,"article-title":"Immunity debt: Hospitals need to be prepared in advance for multiple respiratory diseases that tend to co-occur","journal-title":"JBT","doi-asserted-by":null},{"DOI":"10.1186/s12879-022-07192-x","key":"10.1016/j.ijid.2025.108194_bib0037","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":"De Bruyn A, Verellen S, Bruckers L, Geebelen L, Callebaut I, De Pauw I, et al. Secondary infection in COVID-19 critically ill patients: a retrospective single-center evaluation. 2022;22(1):207.","article-title":null,"journal-title":null,"doi-asserted-by":"crossref"},{"DOI":"10.1002/rmv.2295","key":"10.1016/j.ijid.2025.108194_bib0038","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":"Peng J, Fu M, Mei H, Zheng H, Liang G, She X, et al. Efficacy and secondary infection risk of tocilizumab, sarilumab and anakinra in COVID-19 patients: a systematic review and meta-analysis. 2022;32(3):e2295.","article-title":null,"journal-title":null,"doi-asserted-by":"crossref"},{"DOI":"10.1038/s41423-023-01104-y","key":"10.1016/j.ijid.2025.108194_bib0039","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":"Sievers BL, Cheng MT, Csiba K, Meng B, Gupta RKJC, Immunology M. SARS-CoV-2 and innate immunity: the good, the bad, and the “goldilocks”. 2024;21(2):171–83.","article-title":null,"journal-title":null,"doi-asserted-by":"crossref"},{"DOI":"10.2807/1560-7917.ES.2021.26.39.2100894","key":"10.1016/j.ijid.2025.108194_bib0040","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":"Martínez-Baz I, Trobajo-Sanmartín C, Miqueleiz A, Guevara M, Fernández-Huerta M, Burgui C, et al. Product-specific COVID-19 vaccine effectiveness against secondary infection in close contacts, Navarre, Spain, April to August 2021. 2021;26(39):2100894.","article-title":null,"journal-title":null,"doi-asserted-by":"crossref"},{"DOI":null,"key":"10.1016/j.ijid.2025.108194_bib0041","year":"2021","issue":"4","author":"Teijaro","volume":"21","first-page":"195","unstructured":null,"article-title":"COVID-19 vaccines: modes of immune activation and future challenges","journal-title":"NRI","doi-asserted-by":null},{"DOI":"10.2139/ssrn.3931758","key":"10.1016/j.ijid.2025.108194_bib0042","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":"Lazarus R, Baos S, Cappel-Porter H, Carson-Stevens A, Clout M, Culliford L, et al. Safety and immunogenicity of concomitant administration of COVID-19 vaccines (ChAdOx1 or BNT162b2) with seasonal influenza vaccines in adults in the UK (ComFluCOV): a multicentre, randomised, controlled, phase 4 trial. 2021;398(10318):2277–87.","article-title":null,"journal-title":null,"doi-asserted-by":"crossref"},{"DOI":"10.1007/s10865-024-00487-1","key":"10.1016/j.ijid.2025.108194_bib0043","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":"Abad N, Bonner KE, Huang Q, Baack B, Petrin R, Das D, et al. Behavioral and social drivers of COVID-19 vaccination initiation in the US: a longitudinal study March October 2021. 2024;47(3):422–33.","article-title":null,"journal-title":null,"doi-asserted-by":"crossref"},{"DOI":null,"key":"10.1016/j.ijid.2025.108194_bib0044","year":"2025","issue":null,"author":"Taira","volume":"27","first-page":null,"unstructured":null,"article-title":"The Association Between COVID-19 Vaccination Uptake and Information-Seeking Behaviors Using the Internet: Nationwide Cross-Sectional Study","journal-title":"JoMIR","doi-asserted-by":null},{"DOI":"10.1126/sciimmunol.add4853","key":"10.1016/j.ijid.2025.108194_bib0045","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":"Tang J, Zeng C, Cox TM, Li C, Son YM, Cheon IS, et al. Respiratory mucosal immunity against SARS-CoV-2 after mRNA vaccination. 2022;7(76):eadd4853.","article-title":null,"journal-title":null,"doi-asserted-by":"crossref"}],"short-title":[],"update-policy":"https://doi.org/10.1016/elsevier_cm_policy","alternative-id":["S1201971225004163"],"article-number":"108194","content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"original-title":[],"container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2025,11]]},"reference-count":45,"published-online":null,"references-count":45,"short-container-title":["International Journal of Infectious Diseases"],"is-referenced-by-count":0},"unpaywall":{"doi":"10.1016/j.ijid.2025.108194","is_oa":true,"title":"Incidence of Respiratory Infections after the COVID-19 Pandemic (2023–2024) and Its Association of Vaccination Among Entire Populations in Korea","updated":"2025-11-09T00:29:14+00:00","published_date":"2025-11-01","best_oa_location":{"url":"https://doi.org/10.1016/j.ijid.2025.108194","pmh_id":null,"url_for_pdf":null,"url_for_landing_page":"https://doi.org/10.1016/j.ijid.2025.108194"}}},"created_at":"2025-12-04T03:42:26.941Z","updated_at":"2025-12-08T12:24:58.509Z","tags":[{"paper_doi":"10.1016/j.ijid.2025.108194","tag_type":"age_group","value":"mixed","value_numeric":null},{"paper_doi":"10.1016/j.ijid.2025.108194","tag_type":"category","value":"Infectious Diseases","value_numeric":null},{"paper_doi":"10.1016/j.ijid.2025.108194","tag_type":"condition","value":"Influenza-Like Illness","value_numeric":null},{"paper_doi":"10.1016/j.ijid.2025.108194","tag_type":"condition","value":"Pertussis","value_numeric":null},{"paper_doi":"10.1016/j.ijid.2025.108194","tag_type":"condition","value":"Pneumonia","value_numeric":null},{"paper_doi":"10.1016/j.ijid.2025.108194","tag_type":"condition","value":"Upper Respiratory Tract Infection","value_numeric":null},{"paper_doi":"10.1016/j.ijid.2025.108194","tag_type":"level_of_evidence","value":"3","value_numeric":null},{"paper_doi":"10.1016/j.ijid.2025.108194","tag_type":"sample_size","value":"n=51,645,564","value_numeric":51645564},{"paper_doi":"10.1016/j.ijid.2025.108194","tag_type":"study_design","value":"Retrospective Cohort","value_numeric":null},{"paper_doi":"10.1016/j.ijid.2025.108194","tag_type":"warning","value":"Abstract text appears truncated; results on vaccine‑dose associations are incomplete.","value_numeric":null},{"paper_doi":"10.1016/j.ijid.2025.108194","tag_type":"warning","value":"Design combines national time‑series modeling with cohort hazard analyses; study design label may be imprecise.","value_numeric":null},{"paper_doi":"10.1016/j.ijid.2025.108194","tag_type":"warning","value":"Only relative changes are reported; absolute case counts are not provided in the excerpt.","value_numeric":null}],"summaries":{"what_studied":"A nationwide analysis using integrated insurance claims and vaccination records for the entire Korean population (N=51,645,564) evaluated respiratory infection trends from pre‑pandemic (2017–2019) through the pandemic and into 2023–2024. It also examined the association between the number of COVID‑19 vaccine doses received by June 1, 2023 and subsequent respiratory infections using SARIMAX, Cox hazard, and Fine‑Gray models.","key_result":"Compared with 2017–2019, influenza‑like illness (ILI) and pneumonia incidences fell by over 90% during 2020–2021, then upper respiratory tract infections and common colds resurged in 2023–2024; pertussis incidence rose 46‑fold above expected in late 2023.","practice_takeaway":"In Korea, anticipate a rebound of URIs/common colds in 2023–2024 and a sharp pertussis surge in late 2023; keep a low threshold for testing and case detection for pertussis."}},{"doi":"10.1001/jamapediatrics.2025.4185","pmid":"41143818","title":"State Repeal of Nonmedical Vaccine Exemptions and Kindergarten Vaccination Rates","journal_title":"JAMA Pediatrics","journal_issn":"2168-6203","published_at":"2025-10-27T00:00:00.000Z","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC12560026/","source_score":167,"is_retracted":false,"is_open_access":true,"raw_metadata":{"ooir":{"day":"2026-01-10","doi":"10.1001/jamapediatrics.2025.4185","days":"14","issn":"2168-6203","rank":"3","field":"Clinical Medicine","score":"167","category":"Pediatrics","categories":["Pediatrics"],"_categories":["Pediatrics"]},"pubmed":{"doi":"10.1001/jamapediatrics.2025.4185","title":"State Repeal of Nonmedical Vaccine Exemptions and Kindergarten Vaccination Rates.","journal":"JAMA pediatrics","methods":"","results":"Among 4 states with total repeal affecting approximately 2.8 million kindergarten students, repeal of nonmedical exemptions reduced overall exemption rates by 3.2 (95% CI, 1.9-4.4) percentage points within 3 years. Compared with nonrepeal states, vaccination rates rose by 4.1 (95% CI, 3.3-4.9) percentage points for DTaP, 2.8 (95% CI, 2.1-3.5) percentage points for hepatitis B, 4.0 (95% CI, 3.1-4.9) percentage points for MMR, and 3.8 (95% CI, 2.9-4.6) percentage points for polio. Minimal substitution toward medical exemptions occurred, an increase of only 0.4 (95% CI, 0.04-0.7) percentage points. Partial repeal of nonmedical exemptions demonstrated smaller, less persistent increases in vaccination rates.","abstract":"$33","keywords":[],"pubmed_id":"41143818","conclusions":"","publication_date":"2025-10-27T00:00:00"},"crossref":{"DOI":"10.1001/jamapediatrics.2025.4185","URL":"https://doi.org/10.1001/jamapediatrics.2025.4185","ISSN":["2168-6203"],"link":[{"URL":"https://jamanetwork.com/journals/jamapediatrics/articlepdf/2840422/jamapediatrics_bald_2025_oi_250058_1766435170.07416.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"page":"56","type":"journal-article","issue":"1","score":1,"title":["State Repeal of Nonmedical Vaccine Exemptions and Kindergarten Vaccination Rates"],"author":[{"given":"Anthony","family":"Bald","sequence":"first","affiliation":[{"name":"Harvard Kennedy School, Cambridge, Massachusetts"},{"name":"Department of Economics, California State University, Fullerton, Fullerton"}]},{"given":"Samantha","family":"Gold","sequence":"additional","affiliation":[{"name":"Jeb E. Brooks School of Public Policy, Cornell University, Ithaca, New York"}]},{"given":"Y. Tony","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Health Policy and Management, Milken Institute School of Public Health, The George Washington University, Washington, DC"}]}],"issued":{"date-parts":[[2026,1,1]]},"member":"10","prefix":"10.1001","source":"Crossref","volume":"180","created":{"date-time":"2025-10-27T15:31:20Z","timestamp":1761579080000,"date-parts":[[2025,10,27]]},"indexed":{"date-time":"2026-01-15T09:38:34Z","timestamp":1768469914778,"date-parts":[[2026,1,15]]},"subject":[],"abstract":"$34","language":"en","relation":{},"resource":{"primary":{"URL":"https://jamanetwork.com/journals/jamapediatrics/fullarticle/2840422"}},"subtitle":[],"deposited":{"date-time":"2026-01-05T16:00:49Z","timestamp":1767628849000,"date-parts":[[2026,1,5]]},"issn-type":[{"type":"print","value":"2168-6203"}],"published":{"date-parts":[[2026,1,1]]},"publisher":"American Medical Association (AMA)","reference":[{"DOI":"10.1016/j.vaccine.2022.06.033","key":"poi250058r2","year":"2022","issue":"32","author":"Gambrell","volume":"40","first-page":"4574","unstructured":null,"article-title":"Estimating the number of US children susceptible to measles resulting from COVID-19-related vaccination coverage declines.","journal-title":"Vaccine","doi-asserted-by":"publisher"},{"DOI":"10.2105/AJPH.2013.301538","key":"poi250058r3","year":"2014","issue":"2","author":"Yang","volume":"104","first-page":"371","unstructured":null,"article-title":"A longitudinal analysis of the effect of nonmedical exemption law and vaccine uptake on vaccine-targeted disease rates.","journal-title":"Am J Public Health","doi-asserted-by":"publisher"},{"DOI":"10.1056/NEJM200102013440511","key":"poi250058r4","year":"2001","issue":"5","author":"Albert","volume":"344","first-page":"375","unstructured":null,"article-title":"The last smallpox epidemic in Boston and the vaccination controversy, 1901-1903.","journal-title":"N Engl J Med","doi-asserted-by":"publisher"},{"DOI":"10.1080/14760584.2019.1562344","key":"poi250058r5","year":"2019","issue":"2","author":"Bednarczyk","volume":"18","first-page":"175","unstructured":null,"article-title":"Current landscape of nonmedical vaccination exemptions in the United States: impact of policy changes.","journal-title":"Expert Rev Vaccines","doi-asserted-by":"publisher"},{"DOI":"10.2105/AJPH.2004.046193","key":"poi250058r6","year":"2005","issue":"5","author":"Salmon","volume":"95","first-page":"778","unstructured":null,"article-title":"Public health and the politics of school immunization requirements.","journal-title":"Am J Public Health","doi-asserted-by":"publisher"},{"DOI":"10.1377/hlthaff.2014.1428","key":"poi250058r7","year":"2015","issue":"8","author":"Bradford","volume":"34","first-page":"1383","unstructured":null,"article-title":"Some state vaccination laws contribute to greater exemption rates and disease outbreaks in the United States.","journal-title":"Health Aff (Millwood)","doi-asserted-by":"publisher"},{"DOI":"10.1377/hlthaff.2013.0239","key":"poi250058r8","year":"2013","issue":"7","author":"Blank","volume":"32","first-page":"1282","unstructured":null,"article-title":"Exempting schoolchildren from immunizations: states with few barriers had highest rates of nonmedical exemptions.","journal-title":"Health Aff (Millwood)","doi-asserted-by":"publisher"},{"DOI":"10.1016/j.jhealeco.2021.102480","key":"poi250058r9","year":"2021","issue":null,"author":"Churchill","volume":"78","first-page":null,"unstructured":null,"article-title":"How important is the structure of school vaccine requirement opt-out provisions? Evidence from Washington, DC’s HPV vaccine requirement.","journal-title":"J Health Econ","doi-asserted-by":"publisher"},{"DOI":"10.1001/jama.296.14.1757","key":"poi250058r10","year":"2006","issue":"14","author":"Omer","volume":"296","first-page":"1757","unstructured":null,"article-title":"Nonmedical exemptions to school immunization requirements: secular trends and association of state policies with pertussis incidence.","journal-title":"JAMA","doi-asserted-by":"publisher"},{"DOI":"10.15585/mmwr.mm7341a3","key":"poi250058r11","year":"2024","issue":"41","author":"Seither","volume":"73","first-page":"925","unstructured":null,"article-title":"Coverage with selected vaccines and exemption rates among children in kindergarten—United States, 2023–24 school year.","journal-title":"MMWR Morb Mortal Wkly Rep","doi-asserted-by":"publisher"},{"DOI":"10.1001/jamapediatrics.2021.4251","key":"poi250058r12","year":"2022","issue":"1","author":"DeSilva","volume":"176","first-page":"68","unstructured":null,"article-title":"Association of the COVID-19 pandemic with routine childhood vaccination rates and proportion up to date with vaccinations across 8 US health systems in the Vaccine Safety Datalink.","journal-title":"JAMA Pediatr","doi-asserted-by":"publisher"},{"DOI":"10.1001/jama.2025.8952","key":"poi250058r13","year":"2025","issue":"8","author":"Dong","volume":"334","first-page":"730","unstructured":null,"article-title":"Trends in county-level MMR vaccination coverage in children in the United States.","journal-title":"JAMA","doi-asserted-by":"publisher"},{"DOI":"10.1016/j.jeconom.2021.03.014","key":"poi250058r19","year":"2021","issue":null,"author":"Goodman-Bacon","volume":"225","first-page":"254","unstructured":null,"article-title":"Difference-in-differences with variation in treatment timing.","journal-title":"J Econom","doi-asserted-by":"publisher"},{"DOI":"10.1016/j.jeconom.2020.12.001","key":"poi250058r20","year":"2021","issue":"2","author":"Callaway","volume":"225","first-page":"200","unstructured":null,"article-title":"Difference-in-differences with multiple time periods.","journal-title":"J Econom","doi-asserted-by":"publisher"},{"DOI":"10.1016/j.jeconom.2020.09.006","key":"poi250058r21","year":"2021","issue":"2","author":"Sun","volume":"225","first-page":"175","unstructured":null,"article-title":"Estimating dynamic treatment effects in event studies with heterogeneous treatment effects.","journal-title":"J Econom","doi-asserted-by":"publisher"},{"DOI":"10.1093/restud/rdae007","key":"poi250058r22","year":"2024","issue":"6","author":"Borusyak","volume":"91","first-page":"3253","unstructured":null,"article-title":"Revisiting event-study designs: robust and efficient estimation.","journal-title":"Rev Econ Stud","doi-asserted-by":"publisher"},{"DOI":"10.1257/aer.20181169","key":"poi250058r23","year":"2020","issue":"9","author":"De Chaisemartin","volume":"110","first-page":"2964","unstructured":null,"article-title":"Two-way fixed effects estimators with heterogeneous treatment effects.","journal-title":"Am Econ Rev","doi-asserted-by":"publisher"},{"DOI":"10.1162/rest_a_01414","key":"poi250058r24","year":"2024","issue":null,"author":"De Chaisemartin","volume":null,"first-page":"1","unstructured":null,"article-title":"Difference-in-differences estimators of intertemporal treatment effects.","journal-title":"Rev Econ Stat","doi-asserted-by":"publisher"},{"DOI":"10.1001/jamapediatrics.2015.4856","key":"poi250058r26","year":"2016","issue":"6","author":"Delamater","volume":"170","first-page":"619","unstructured":null,"article-title":"California Senate Bill 277’s grandfather clause and nonmedical vaccine exemptions in California, 2015–2022.","journal-title":"JAMA Pediatr","doi-asserted-by":"publisher"},{"DOI":"10.1001/jama.2017.9242","key":"poi250058r27","year":"2017","issue":"9","author":"Delamater","volume":"318","first-page":"863","unstructured":null,"article-title":"Change in medical exemptions from immunization in California after elimination of personal belief exemptions.","journal-title":"JAMA","doi-asserted-by":"publisher"},{"DOI":"10.1016/j.jhealeco.2011.06.003","key":"poi250058r28","year":"2011","issue":"5","author":"Abrevaya","volume":"30","first-page":"966","unstructured":null,"article-title":"Effectiveness of state-level vaccination mandates: evidence from the varicella vaccine.","journal-title":"J Health Econ","doi-asserted-by":"publisher"},{"DOI":"10.1016/j.jhealeco.2021.102464","key":"poi250058r29","year":"2021","issue":null,"author":"Hair","volume":"78","first-page":null,"unstructured":null,"article-title":"Personal belief exemptions for school-entry vaccinations, vaccination rates, and academic achievement.","journal-title":"J Health Econ","doi-asserted-by":"publisher"},{"DOI":"10.1257/pol.20170067","key":"poi250058r31","year":"2019","issue":"1","author":"Carpenter","volume":"11","first-page":"95","unstructured":null,"article-title":"Direct and spillover effects of middle school vaccination requirements.","journal-title":"Am Econ J Econ Policy","doi-asserted-by":"publisher"},{"DOI":"10.1001/jama.2019.7924","key":"poi250058r32","year":"2019","issue":"1","author":"Pingali","volume":"322","first-page":"49","unstructured":null,"article-title":"Associations of statewide legislative and administrative interventions with vaccination status among kindergartners in California.","journal-title":"JAMA","doi-asserted-by":"publisher"},{"DOI":"10.1001/jamanetworkopen.2023.54710","key":"poi250058r33","year":"2024","issue":"2","author":"Correira","volume":"7","first-page":null,"unstructured":null,"article-title":"School vaccine coverage and medical exemption uptake after the New York State repeal of nonmedical vaccination exemptions.","journal-title":"JAMA Netw Open","doi-asserted-by":"publisher"},{"DOI":"10.1542/peds.2018-3301","key":"poi250058r34","year":"2019","issue":"6","author":"Delamater","volume":"143","first-page":null,"unstructured":null,"article-title":"Elimination of nonmedical immunization exemptions in California and school-entry vaccine status.","journal-title":"Pediatrics","doi-asserted-by":"publisher"},{"DOI":"10.1001/jama.2023.16995","key":"poi250058r35","year":"2023","issue":"16","author":"Delamater","volume":"330","first-page":"1585","unstructured":null,"article-title":"Kindergarten vaccination status in California after changes to medical exemption policy.","journal-title":"JAMA","doi-asserted-by":"publisher"},{"DOI":"10.1016/j.labeco.2025.102715","key":"poi250058r36","year":"2025","issue":null,"author":"Abouk","volume":"96","first-page":null,"unstructured":null,"article-title":"Promoting public health with blunt instruments: evidence from vaccine mandates.","journal-title":"Labour Econ","doi-asserted-by":"publisher"},{"DOI":"10.1111/risa.14090","key":"poi250058r37","year":"2023","issue":"10","author":"Ferranna","volume":"43","first-page":"2053","unstructured":null,"article-title":"The benefits and costs of U.S. employer COVID-19 vaccine mandates.","journal-title":"Risk Anal","doi-asserted-by":"publisher"},{"DOI":"10.1207/s15324796abm3202_10","key":"poi250058r39","year":"2006","issue":"2","author":"Rutter","volume":"32","first-page":"127","unstructured":null,"article-title":"An implementation intentions intervention to increase uptake of mammography.","journal-title":"Ann Behav Med","doi-asserted-by":"publisher"},{"DOI":"10.1016/j.vaccine.2022.08.060","key":"poi250058r40","year":"2022","issue":"43","author":"Jacobson","volume":"40","first-page":"6235","unstructured":null,"article-title":"Can financial incentives and other nudges increase COVID-19 vaccinations among the vaccine hesitant? A randomized trial.","journal-title":"Vaccine","doi-asserted-by":"publisher"},{"DOI":"10.1257/pol.20210393","key":"poi250058r41","year":"2024","issue":"1","author":"Alsan","volume":"16","first-page":"394","unstructured":null,"article-title":"Experimental evidence on the effectiveness of nonexperts for improving vaccine demand.","journal-title":"Am Econ J Econ Policy","doi-asserted-by":"publisher"},{"DOI":"10.1257/pandp.20231112","key":"poi250058r43","year":"2023","issue":null,"author":"Ho","volume":"113","first-page":"653","unstructured":null,"article-title":"The impact of large-scale social media advertising campaigns on COVID-19 vaccination: Evidence from two randomized controlled trials.","journal-title":"AEA Pap Proc","doi-asserted-by":"publisher"},{"DOI":"10.1016/j.jhealeco.2017.01.002","key":"poi250058r44","year":"2017","issue":null,"author":"Lawler","volume":"52","first-page":"45","unstructured":null,"article-title":"Effectiveness of vaccination recommendations versus mandates: evidence from the hepatitis A vaccine.","journal-title":"J Health Econ","doi-asserted-by":"publisher"},{"DOI":"10.1073/pnas.1103170108","key":"poi250058r45","year":"2011","issue":"26","author":"Milkman","volume":"108","first-page":"10415","unstructured":null,"article-title":"Using implementation intentions prompts to enhance influenza vaccination rates.","journal-title":"Proc Natl Acad Sci U S A","doi-asserted-by":"publisher"},{"DOI":"10.1001/jama.298.20.2415","key":"poi250058r46","year":"2007","issue":"20","author":"Loewenstein","volume":"298","first-page":"2415","unstructured":null,"article-title":"Asymmetric paternalism to improve health behaviors.","journal-title":"JAMA","doi-asserted-by":"publisher"},{"DOI":"10.1136/bmjgh-2022-008684","key":"poi250058r47","year":"2022","issue":"5","author":"Bardosh","volume":"7","first-page":null,"unstructured":null,"article-title":"The unintended consequences of COVID-19 vaccine policy: why mandates, passports and restrictions may cause more harm than good.","journal-title":"BMJ Glob Health","doi-asserted-by":"publisher"},{"DOI":"10.1080/21645515.2023.2261176","key":"poi250058r48","year":"2023","issue":"2","author":"Correira","volume":"19","first-page":null,"unstructured":null,"article-title":"Exploring the impact of the New York State repeal of nonmedical vaccination exemptions on student enrollment, absenteeism, and school workload: perspectives from a survey of school administrators.","journal-title":"Hum Vaccin Immunother","doi-asserted-by":"publisher"},{"DOI":"10.1001/jamanetworkopen.2021.46467","key":"poi250058r49","year":"2022","issue":"2","author":"Patel","volume":"5","first-page":null,"unstructured":null,"article-title":"Evaluation of trends in homeschooling rates after elimination of nonmedical exemptions to childhood immunizations in California, 2012–2020.","journal-title":"JAMA Netw Open","doi-asserted-by":"publisher"},{"DOI":"10.1056/NEJMsa0806477","key":"poi250058r51","year":"2009","issue":"19","author":"Omer","volume":"360","first-page":"1981","unstructured":null,"article-title":"Vaccine refusal, mandatory immunization, and the risks of vaccine-preventable diseases.","journal-title":"N Engl J Med","doi-asserted-by":"publisher"},{"DOI":null,"key":"poi250058r30","year":"2019","issue":null,"author":"Richwine","volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":null},{"DOI":null,"key":"poi250058r38","year":"2024","issue":null,"author":"Gandhi","volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":null},{"DOI":null,"key":"poi250058r42","year":"2024","issue":null,"author":"Campos-Mercade","volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":null},{"DOI":null,"key":"poi250058r1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":"Centers for Disease Control and Prevention. Measles cases and outbreaks: measles (rubeola). Updated August 6, 2025. Accessed August 17, 2025. https://www.cdc.gov/measles/data-research/index.html","article-title":null,"journal-title":null,"doi-asserted-by":null},{"DOI":null,"key":"poi250058r14","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":"Jones? JM. Far fewer in U.S. regard childhood vaccinations as important. Gallup News. August 7, 2024. Accessed August 17, 2025. https://news.gallup.com/poll/648308/far-fewer-regard-childhood-vaccinations-important.aspx","article-title":null,"journal-title":null,"doi-asserted-by":null},{"DOI":null,"key":"poi250058r15","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":"Centers for Disease Control and Prevention. Vaccination coverage and exemptions among kindergartners. SchoolVaxView. Updated October 2, 2024. Accessed December 17, 2024. https://www.cdc.gov/schoolvaxview/index.html","article-title":null,"journal-title":null,"doi-asserted-by":null},{"DOI":null,"key":"poi250058r16","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":"National Archives. Code of federal regulations: 45 CFR § 46.102. 2025. Accessed September 1, 2025. https://www.ecfr.gov/current/title-45/subtitle-A/subchapter-A/part-46/section-46.102","article-title":null,"journal-title":null,"doi-asserted-by":null},{"DOI":null,"key":"poi250058r17","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":"National Conference of State Legislatures. State non-medical exemptions from school immunization requirements. Updated August 13, 2024. Accessed December 17, 2024. https://www.ncsl.org/health/state-non-medical-exemptions-from-school-immunization-requirements","article-title":null,"journal-title":null,"doi-asserted-by":null},{"DOI":null,"key":"poi250058r18","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":"Baker? A, Callaway? B, Cunningham? S, Goodman-Bacon? A, Sant’Anna? PHC. Difference-in-differences designs: a practitioner’s guide.? arXiv. Preprint posted online March 17, 2025. Accessed March 20, 2025. doi:10.48550/arXiv.2503.13323","article-title":null,"journal-title":null,"doi-asserted-by":null},{"DOI":null,"key":"poi250058r25","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":"Freyaldenhoven? S, Hansen? C, Pérez Pérez? J, Shapiro? JM. Visualization, identification, and estimation in the linear panel event-study design. Working paper 29170. National Bureau of Economic Research. Accessed September 1, 2025. http://www.nber.org/papers/w29170","article-title":null,"journal-title":null,"doi-asserted-by":null},{"DOI":"10.1101/2025.08.11.25333447","key":"poi250058r50","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":"Correira? JW, Morrison? KT, Doll? MK. Homeschooling trends before and after the New York state repeal of nonmedical vaccination exemptions.? medRxiv. Preprint posted online August 13, 2025. doi:10.1101/2025.08.11.25333447?","article-title":null,"journal-title":null,"doi-asserted-by":"crossref"}],"short-title":[],"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1,1]]}},"content-domain":{"domain":[],"crossmark-restriction":false},"original-title":[],"container-title":["JAMA Pediatrics"],"published-print":{"date-parts":[[2026,1,1]]},"reference-count":51,"published-online":null,"references-count":51,"short-container-title":["JAMA Pediatr"],"is-referenced-by-count":3},"unpaywall":{"doi":"10.1001/jamapediatrics.2025.4185","is_oa":true,"title":"State Repeal of Nonmedical Vaccine Exemptions and Kindergarten Vaccination Rates","updated":"2026-01-10T04:46:20+00:00","published_date":"2025-10-27","best_oa_location":{"url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC12560026/","pmh_id":"oai:pubmedcentral.nih.gov:12560026","url_for_pdf":null,"url_for_landing_page":"https://pmc.ncbi.nlm.nih.gov/articles/PMC12560026/"}}},"created_at":"2026-01-14T18:30:49.575Z","updated_at":"2026-01-21T12:05:26.220Z","tags":[{"paper_doi":"10.1001/jamapediatrics.2025.4185","tag_type":"age_group","value":"child","value_numeric":null},{"paper_doi":"10.1001/jamapediatrics.2025.4185","tag_type":"category","value":"Pediatrics","value_numeric":null},{"paper_doi":"10.1001/jamapediatrics.2025.4185","tag_type":"condition","value":"Hepatitis B","value_numeric":null},{"paper_doi":"10.1001/jamapediatrics.2025.4185","tag_type":"condition","value":"Measles","value_numeric":null},{"paper_doi":"10.1001/jamapediatrics.2025.4185","tag_type":"condition","value":"Pertussis","value_numeric":null},{"paper_doi":"10.1001/jamapediatrics.2025.4185","tag_type":"condition","value":"Poliomyelitis","value_numeric":null},{"paper_doi":"10.1001/jamapediatrics.2025.4185","tag_type":"level_of_evidence","value":"5","value_numeric":null},{"paper_doi":"10.1001/jamapediatrics.2025.4185","tag_type":"sex","value":"mixed","value_numeric":null},{"paper_doi":"10.1001/jamapediatrics.2025.4185","tag_type":"study_design","value":"Cross-Sectional","value_numeric":null},{"paper_doi":"10.1001/jamapediatrics.2025.4185","tag_type":"warning","value":"Design described as cross-sectional with a difference-in-differences approach; labeled as cross-sectional for tagging simplicity.","value_numeric":null},{"paper_doi":"10.1001/jamapediatrics.2025.4185","tag_type":"warning","value":"Outcomes are state-level aggregates; individual-level effects are not reported.","value_numeric":null},{"paper_doi":"10.1001/jamapediatrics.2025.4185","tag_type":"warning","value":"Population size is approximate (~2.8 million kindergarteners) as reported; exact N not provided.","value_numeric":null}],"summaries":{"what_studied":"Annual state-level kindergarten vaccination and exemption data from 2011–2023 were analyzed using a staggered difference-in-differences, comparing states that repealed nonmedical exemptions with states that kept them. Total repeal occurred in California (2015), New York (2019), Maine (2019), and Connecticut (2021); partial repeal in Vermont (2015) and Washington (2019).","key_result":"Across four total-repeal states (~2.8 million kindergarteners), overall exemptions fell by 3.2 percentage points within 3 years (95% CI, 1.9–4.4). Versus nonrepeal states, vaccination rose: DTaP +4.1 (95% CI, 3.3–4.9), hepatitis B +2.8 (95% CI, 2.1–3.5), MMR +4.0 (95% CI, 3.1–4.9), and polio +3.8 (95% CI, 2.9–4.6); medical exemptions increased only 0.4 points (95% CI, 0.04–0.7). Partial repeals showed smaller, less durable gains.","practice_takeaway":"Repealing nonmedical vaccine exemptions was associated with higher kindergarten vaccination coverage and minimal substitution to medical exemptions. During a period of heightened vaccine hesitancy, repeal appeared to help maintain coverage in repeal states."}}],"initialOffset":5,"fetchConfig":{"kind":"tags","tags":[{"tag_type":"condition","value":"Pertussis"}]},"breadcrumbItems":[{"name":"Home","href":"/"},{"name":"Research Hub","href":"/hub"},{"name":"Conditions","href":"/hub/tag/condition"},{"name":"Pertussis"}],"hrefConfig":{"basePath":"/hub/papers","webViewQueryParams":{"hub_ctx":"tag","hub_tag_type":"condition","hub_tag_value":"Pertussis"}}}]]

Papers